Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
about
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancerRole of positron emission tomography-computed tomography in non-small cell lung cancerA new needle on the block: EchoTip ProCore endobronchial ultrasound needleExtra-cardiac findings in cardiovascular magnetic resonance: what the imaging cardiologist needs to knowReview of current and evolving clinical indications for endoscopic ultrasoundEvaluation of lymph node metastasis in lung cancer: who is the chief justice?Innovative technologies in thoracic radiation therapy for lung cancerThe use and misuse of positron emission tomography in lung cancer evaluationInvolved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF)Epidemiology and management of common pulmonary diseases in older personsEndoscopic ultrasound: an overview of its role in current clinical practiceComputer-aided diagnosis for early-stage lung cancer based on longitudinal and balanced data.Unified Least Squares Methods for the Evaluation of Diagnostic Tests With the Gold StandardMultidisciplinary Evaluation of Patients With Suspected Lung Cancer.Positron emission tomography/computerized tomography in lung cancer.Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.A Novel Strategy for Surface Modification of Superparamagnetic Iron Oxide Nanoparticles for Lung Cancer ImagingEndosonographic features predictive of malignancy in mediastinal lymph nodes in patients with lung cancer.N2 disease in T1 non-small cell lung cancer.Contourlet textual features: improving the diagnosis of solitary pulmonary nodules in two dimensional CT imagesEvaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation.CT of thoracic lymph nodes. Part II: diseases and pitfalls.Specific organ metastases and survival in metastatic non-small-cell lung cancer.A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.Plasma microRNAs as potential biomarkers for non-small-cell lung cancerRatio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer.Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma.Preoperative nodal staging of non-small cell lung cancer using 99mTc-sestamibi spect/ct imagingAppropriateness criteria of FDG PET/CT in oncology.Clinical and surgical-pathological staging in early non-small cell lung cancer.Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.Direct nodal sampling by echoendoscopy in lung cancer: the clinician's expectations: Direct nodal sampling by echoendoscopy in lung cancer.Diagnostic value of bone-specific alkaline phosphatase in lung carcinoma patients with bone metastases: a meta-analysisNegative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis.Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.Hilar lymph node eroding into the pulmonary artery diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.
P2860
Q21245710-A9373A19-6C78-473F-8773-437B8DFA7325Q26750666-4510B919-DED7-4686-B5F3-D822C24E1A38Q26751329-223D6625-DAB2-4F8F-B828-5113A2E8966FQ26751355-11E0A6D0-6257-4C1F-A98E-193418F9C7ACQ26767113-4FD7F80A-7C23-4329-A26C-0D44BF28F27BQ26774986-7E25C99E-5519-426E-95FC-BFC690FB67A2Q26863239-1557A3AB-6763-44E1-98BE-782587E7B0D0Q27021838-F746FBD6-6F15-4572-A6ED-3D6BF0D6F696Q28073534-6ACA7FAD-BA86-4C81-82C9-ED7E730255ECQ28397465-A733AF5E-4291-4A66-96B4-69D19D7AA8D0Q30363551-0889ACB3-00DF-4F88-BB93-AF94BBDE83E5Q30629730-E81C7412-72DE-4768-9EB8-DB320C96224FQ33565913-75FA3F5D-6315-44BA-8A29-AA2E9CF69D02Q33599661-318EACCB-5825-49B8-BD0D-DEB654B03199Q33657999-8CC69E79-7694-425D-B800-E03FA00F853DQ33751205-15D639A0-2796-4D33-A8E2-18287C5C8683Q33756981-98A8C7AD-3490-4555-AE51-3006CFA6F731Q33874281-73301C76-D2AB-4734-9F53-A238FE72CDDBQ34077867-5BCAAC98-26BA-4CFB-9B2B-1F988A5545F7Q34094782-2995CB44-8AC7-434C-A369-437F8A7E6A6FQ34255107-39AB0F13-51C7-4D38-904A-AAC472011C87Q34504713-0E23E804-C3CC-4953-8B6C-28C2AEBED2CDQ34518089-3566BECD-1966-4A33-82F8-3146FC993334Q34607284-664F2037-A421-42D7-8084-6C29824E7D9EQ35050792-1ACD0CC2-2654-49B6-92F9-6509CEDA9C7CQ35087819-066AC6CA-B75B-47B2-AAA7-0C8F6F9AE688Q35200620-7DC4D435-1BD3-454E-AA01-8485C75B6363Q35240586-DE683E46-60E7-43C3-A2D4-C4262522FF46Q35473285-F924DEF3-9CBA-49FE-A6AF-075883F611E2Q35568776-4116787B-EEB8-4BB4-A41B-5DFBB3DED01FQ35569308-E126A038-1E67-48DA-A035-7A7C5AB48F21Q35661959-510A58BE-C4F6-4A90-8CDB-091E79B2D11FQ35675562-B705E949-E1B0-417D-88AB-0661ECD62332Q35894852-2546CFE9-A50E-4D2E-94B0-60DB8946C36BQ35941636-5033AA0E-8274-4D40-A14F-D51F186B84BAQ35971034-23CA5141-E0DB-44A9-9B7B-8057F8253DF2Q35979047-DB610829-2EED-4846-8D8E-91414B30C80AQ36014679-4D01F55C-FE19-4AE7-9029-866096B57DF4Q36073657-5FC60027-A5AB-48B6-A43F-2644772151ECQ36101421-5BF43738-5FA4-40AB-AE80-817A71D4C6C4
P2860
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
@ast
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
@en
type
label
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
@ast
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
@en
prefLabel
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
@ast
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
@en
P1433
P1476
Noninvasive staging of non-small cell lung cancer: a review of the current evidence
@en
P2093
Eric M Toloza
Linda Harpole
P304
P356
10.1378/CHEST.123.1_SUPPL.137S
P407
P433
P577
2003-01-01T00:00:00Z